Liquidia Corp Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on March 13, 2024)
- Description of Securities of the Company (Filed With SEC on March 13, 2024)
- Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on August 10, 2023)
- Fourth Amendment to Promotion Agreement, dated as of March 10, 2023, by and between Liquidia PAH, LLC and Sandoz Inc (Filed With SEC on May 8, 2023)
- Liquidia Corporation 2022 Inducement Plan (Filed With SEC on January 31, 2022)
- Standstill Agreement, dated as of April 13, 2021, by and among Liquidia Corporation and Caligan Partners LP (Filed With SEC on April 13, 2021)
- Description of Securities of the Company (Filed With SEC on March 25, 2021)
- First Amendment to Promotion Agreement, effective as of May 8, 2020, by and between RareGen, LLC and Sandoz Inc (Filed With SEC on August 5, 2020)
- Promotion Agreement, dated as of August 1, 2018, by and between RareGen, LLC and Sandoz Inc (Filed With SEC on August 5, 2020)
- Form of Lock-Up Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc. and each of the RareGen members party thereto (Filed With SEC on August 5, 2020)
- Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Eshelman Ventures, LLC and Fredric N. Eshelman, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)
- Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Canaan VIII L.P., dated as of June 29, 2020 (Filed With SEC on August 5, 2020)
- Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Neal F. Fowler, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)
